A 39-year-old HIV-positive black African woman with previously treated cerebral toxoplasmosis experienced a foetal intra-uterine death due to congenital toxoplasmosis. This case demonstrates the complexities of screening for maternal toxoplasmosis in the context of pregnancy and HIV infection-related cell-mediated immunosuppression. Additionally, the case highlights the challenges in providing effective preventative and therapeutic drug options for congenital toxoplasmosis.
NelsonMDockrellDEdwardsS.British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. HIV Med2011;
12: 1–5.
2.
CamposFAQueiroz De AndradeGMDeAet al.
Incidence of congenital toxoplasmosis among infants born to HIV-coinfected mothers: case series and literature review. Braz J Infect Dis2014;
1: 609–617.
3.
BiedermannKFleppMFierzWet al.
Pregnancy, immunosuppression and reactivation of latent toxoplasmosis. J Perinat Med1995;
23: 191–203.
4.
MontoyaJGRemingtonJSRemingtonJS.Clinical practice: management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis2008;
47: 554–566.
5.
BertschySOpravilMCavassiniMet al.
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy. Clin Microbiol Infect2006;
12: 666–671.
6.
DubeyJPJonesJL.Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol2008;
38: 1257–1278.
7.
GarwegJGScherrerJWallonMet al.
Reactivation of ocular toxoplasmosis during pregnancy. BJOG2005;
112: 241–242.
8.
TekkesinN.Diagnosis of toxoplasmosis in pregnancy: a review. HOAJ Biol2012;
1: 9.
9.
RomandSWallonMFranckJet al.
Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol2001;
97: 296–300.
10.
ZuidemaJHilbers-ModdermanESMMerkusFWHM.Clinical pharmacokinetics of dapsone. Clin Pharmacokinet1986;
11: 299–315.
11.
NewmanRDPariseMESlutskerLet al.
Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. Trop Med Int Health2003;
8: 488–506.
12.
ThorntonYSBoweET.Neonatal hyperbilirubinemia after treatment of maternal leprosy. South Med J1989;
82: 668.
